GO:0004832 | valine-tRNA ligase activity | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 1 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 1 |
GO:0048291 | isotype switching to IgG isotypes | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 1 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 1 |
GO:0002368 | B cell cytokine production | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 1 |
GO:0006458 | 'de novo' protein folding | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 2 |
GO:0048742 | regulation of skeletal muscle fiber development | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 2 |
GO:0006684 | sphingomyelin metabolic process | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 2 |
GO:0004647 | phosphoserine phosphatase activity | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 2 |
GO:1903033 | positive regulation of microtubule plus-end binding | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 2 |
GO:0006334 | nucleosome assembly | 6.86e-03 | 1.00e+00 | 3.996 | 2 | 4 | 51 |
GO:0071437 | invadopodium | 7.36e-03 | 1.00e+00 | 7.083 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 7.36e-03 | 1.00e+00 | 7.083 | 1 | 2 | 3 |
GO:0003688 | DNA replication origin binding | 7.36e-03 | 1.00e+00 | 7.083 | 1 | 1 | 3 |
GO:0046696 | lipopolysaccharide receptor complex | 7.36e-03 | 1.00e+00 | 7.083 | 1 | 1 | 3 |
GO:0030135 | coated vesicle | 7.36e-03 | 1.00e+00 | 7.083 | 1 | 1 | 3 |
GO:0006563 | L-serine metabolic process | 7.36e-03 | 1.00e+00 | 7.083 | 1 | 1 | 3 |
GO:0004767 | sphingomyelin phosphodiesterase activity | 7.36e-03 | 1.00e+00 | 7.083 | 1 | 1 | 3 |
GO:0045292 | mRNA cis splicing, via spliceosome | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 2 | 4 |
GO:0006564 | L-serine biosynthetic process | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 4 |
GO:0035519 | protein K29-linked ubiquitination | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 5 |
GO:0006282 | regulation of DNA repair | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 5 |
GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 5 |
GO:0044314 | protein K27-linked ubiquitination | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 5 |
GO:0051082 | unfolded protein binding | 1.26e-02 | 1.00e+00 | 3.539 | 2 | 5 | 70 |
GO:0050847 | progesterone receptor signaling pathway | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 6 |
GO:0085020 | protein K6-linked ubiquitination | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 6 |
GO:0070914 | UV-damage excision repair | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 6 |
GO:0043032 | positive regulation of macrophage activation | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 6 |
GO:0008035 | high-density lipoprotein particle binding | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 6 |
GO:0002199 | zona pellucida receptor complex | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 4 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 2 | 7 |
GO:0000339 | RNA cap binding | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 4 | 7 |
GO:0005845 | mRNA cap binding complex | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 8 |
GO:0006450 | regulation of translational fidelity | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 8 |
GO:0032727 | positive regulation of interferon-alpha production | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 8 |
GO:0031011 | Ino80 complex | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 3 | 8 |
GO:0010388 | cullin deneddylation | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 4 | 8 |
GO:0051604 | protein maturation | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 8 |
GO:0005739 | mitochondrion | 2.00e-02 | 1.00e+00 | 1.626 | 5 | 32 | 659 |
GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 9 |
GO:0010225 | response to UV-C | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 2 | 9 |
GO:0006379 | mRNA cleavage | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 2 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 9 |
GO:0001530 | lipopolysaccharide binding | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 9 |
GO:0005095 | GTPase inhibitor activity | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 10 |
GO:0042026 | protein refolding | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 10 |
GO:0051131 | chaperone-mediated protein complex assembly | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 3 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 4 | 11 |
GO:0008652 | cellular amino acid biosynthetic process | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 11 |
GO:0008334 | histone mRNA metabolic process | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 11 |
GO:0004527 | exonuclease activity | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 4 | 12 |
GO:0002102 | podosome | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 1 | 12 |
GO:0035371 | microtubule plus-end | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 2 | 13 |
GO:0032733 | positive regulation of interleukin-10 production | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 2 | 13 |
GO:0008156 | negative regulation of DNA replication | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 1 | 13 |
GO:0000421 | autophagic vacuole membrane | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 1 | 13 |
GO:0060135 | maternal process involved in female pregnancy | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 3 | 14 |
GO:0050870 | positive regulation of T cell activation | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 1 | 14 |
GO:0001891 | phagocytic cup | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 1 | 14 |
GO:0016575 | histone deacetylation | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 2 | 14 |
GO:0008135 | translation factor activity, nucleic acid binding | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 4 | 15 |
GO:0043034 | costamere | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 15 |
GO:0003887 | DNA-directed DNA polymerase activity | 3.86e-02 | 1.00e+00 | 4.668 | 1 | 2 | 16 |
GO:0042113 | B cell activation | 3.86e-02 | 1.00e+00 | 4.668 | 1 | 1 | 16 |
GO:0042100 | B cell proliferation | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 1 | 17 |
GO:0006513 | protein monoubiquitination | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 1 | 17 |
GO:0031667 | response to nutrient levels | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 2 | 17 |
GO:0031047 | gene silencing by RNA | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 2 | 18 |
GO:0033574 | response to testosterone | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 1 | 18 |
GO:0006913 | nucleocytoplasmic transport | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 2 | 20 |
GO:0070979 | protein K11-linked ubiquitination | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 3 | 20 |
GO:0071897 | DNA biosynthetic process | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 2 | 20 |
GO:0032735 | positive regulation of interleukin-12 production | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 1 | 20 |
GO:0034660 | ncRNA metabolic process | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 1 | 20 |
GO:0051084 | 'de novo' posttranslational protein folding | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 4 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 1 | 22 |
GO:0006687 | glycosphingolipid metabolic process | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 1 | 22 |
GO:0006953 | acute-phase response | 5.74e-02 | 1.00e+00 | 4.083 | 1 | 2 | 24 |
GO:0005881 | cytoplasmic microtubule | 5.74e-02 | 1.00e+00 | 4.083 | 1 | 3 | 24 |
GO:0006370 | 7-methylguanosine mRNA capping | 5.74e-02 | 1.00e+00 | 4.083 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 5.74e-02 | 1.00e+00 | 4.083 | 1 | 6 | 24 |
GO:0070534 | protein K63-linked ubiquitination | 5.74e-02 | 1.00e+00 | 4.083 | 1 | 3 | 24 |
GO:0005654 | nucleoplasm | 5.82e-02 | 1.00e+00 | 1.216 | 5 | 68 | 876 |
GO:0005902 | microvillus | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 1 | 25 |
GO:0009267 | cellular response to starvation | 6.21e-02 | 1.00e+00 | 3.968 | 1 | 1 | 26 |
GO:0050896 | response to stimulus | 6.44e-02 | 1.00e+00 | 3.914 | 1 | 1 | 27 |
GO:0032755 | positive regulation of interleukin-6 production | 6.44e-02 | 1.00e+00 | 3.914 | 1 | 1 | 27 |
GO:0032729 | positive regulation of interferon-gamma production | 6.67e-02 | 1.00e+00 | 3.861 | 1 | 1 | 28 |
GO:0016881 | acid-amino acid ligase activity | 6.67e-02 | 1.00e+00 | 3.861 | 1 | 3 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 6.90e-02 | 1.00e+00 | 3.810 | 1 | 4 | 29 |
GO:0006446 | regulation of translational initiation | 6.90e-02 | 1.00e+00 | 3.810 | 1 | 2 | 29 |
GO:0004842 | ubiquitin-protein transferase activity | 7.09e-02 | 1.00e+00 | 2.185 | 2 | 17 | 179 |
GO:0030670 | phagocytic vesicle membrane | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 1 | 30 |
GO:0051865 | protein autoubiquitination | 7.36e-02 | 1.00e+00 | 3.714 | 1 | 2 | 31 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 7.36e-02 | 1.00e+00 | 3.714 | 1 | 6 | 31 |
GO:0045111 | intermediate filament cytoskeleton | 7.36e-02 | 1.00e+00 | 3.714 | 1 | 3 | 31 |
GO:0042157 | lipoprotein metabolic process | 7.58e-02 | 1.00e+00 | 3.668 | 1 | 4 | 32 |
GO:0042110 | T cell activation | 7.81e-02 | 1.00e+00 | 3.624 | 1 | 2 | 33 |
GO:0007519 | skeletal muscle tissue development | 7.81e-02 | 1.00e+00 | 3.624 | 1 | 2 | 33 |
GO:0006869 | lipid transport | 8.04e-02 | 1.00e+00 | 3.581 | 1 | 2 | 34 |
GO:0000786 | nucleosome | 8.04e-02 | 1.00e+00 | 3.581 | 1 | 2 | 34 |
GO:0007254 | JNK cascade | 8.04e-02 | 1.00e+00 | 3.581 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 8.27e-02 | 1.00e+00 | 3.539 | 1 | 5 | 35 |
GO:0006986 | response to unfolded protein | 8.27e-02 | 1.00e+00 | 3.539 | 1 | 1 | 35 |
GO:0031124 | mRNA 3'-end processing | 8.27e-02 | 1.00e+00 | 3.539 | 1 | 4 | 35 |
GO:0070936 | protein K48-linked ubiquitination | 8.27e-02 | 1.00e+00 | 3.539 | 1 | 1 | 35 |
GO:0044297 | cell body | 8.27e-02 | 1.00e+00 | 3.539 | 1 | 5 | 35 |
GO:0005743 | mitochondrial inner membrane | 8.37e-02 | 1.00e+00 | 2.046 | 2 | 9 | 197 |
GO:0005737 | cytoplasm | 8.52e-02 | 1.00e+00 | 0.628 | 10 | 127 | 2633 |
GO:0003743 | translation initiation factor activity | 8.72e-02 | 1.00e+00 | 3.459 | 1 | 8 | 37 |
GO:0005905 | coated pit | 8.72e-02 | 1.00e+00 | 3.459 | 1 | 2 | 37 |
GO:0006281 | DNA repair | 8.81e-02 | 1.00e+00 | 2.003 | 2 | 24 | 203 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 8.94e-02 | 1.00e+00 | 3.421 | 1 | 4 | 38 |
GO:0006665 | sphingolipid metabolic process | 8.94e-02 | 1.00e+00 | 3.421 | 1 | 1 | 38 |
GO:0006369 | termination of RNA polymerase II transcription | 8.94e-02 | 1.00e+00 | 3.421 | 1 | 5 | 38 |
GO:0042995 | cell projection | 9.62e-02 | 1.00e+00 | 3.311 | 1 | 1 | 41 |
GO:0000775 | chromosome, centromeric region | 9.62e-02 | 1.00e+00 | 3.311 | 1 | 6 | 41 |
GO:0003684 | damaged DNA binding | 9.62e-02 | 1.00e+00 | 3.311 | 1 | 1 | 41 |
GO:0006914 | autophagy | 1.03e-01 | 1.00e+00 | 3.209 | 1 | 1 | 44 |
GO:0030141 | secretory granule | 1.03e-01 | 1.00e+00 | 3.209 | 1 | 2 | 44 |
GO:0006406 | mRNA export from nucleus | 1.03e-01 | 1.00e+00 | 3.209 | 1 | 7 | 44 |
GO:0051087 | chaperone binding | 1.05e-01 | 1.00e+00 | 3.177 | 1 | 3 | 45 |
GO:0003725 | double-stranded RNA binding | 1.05e-01 | 1.00e+00 | 3.177 | 1 | 2 | 45 |
GO:0002039 | p53 binding | 1.05e-01 | 1.00e+00 | 3.177 | 1 | 4 | 45 |
GO:0009612 | response to mechanical stimulus | 1.07e-01 | 1.00e+00 | 3.145 | 1 | 2 | 46 |
GO:0008203 | cholesterol metabolic process | 1.09e-01 | 1.00e+00 | 3.114 | 1 | 2 | 47 |
GO:0006310 | DNA recombination | 1.16e-01 | 1.00e+00 | 3.025 | 1 | 8 | 50 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.20e-01 | 1.00e+00 | 2.968 | 1 | 8 | 52 |
GO:0006302 | double-strand break repair | 1.20e-01 | 1.00e+00 | 2.968 | 1 | 5 | 52 |
GO:0003723 | RNA binding | 1.22e-01 | 1.00e+00 | 1.720 | 2 | 22 | 247 |
GO:0016311 | dephosphorylation | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 3 | 55 |
GO:0044822 | poly(A) RNA binding | 1.28e-01 | 1.00e+00 | 1.026 | 4 | 45 | 799 |
GO:0008584 | male gonad development | 1.31e-01 | 1.00e+00 | 2.836 | 1 | 1 | 57 |
GO:0003697 | single-stranded DNA binding | 1.31e-01 | 1.00e+00 | 2.836 | 1 | 4 | 57 |
GO:0042826 | histone deacetylase binding | 1.33e-01 | 1.00e+00 | 2.810 | 1 | 5 | 58 |
GO:0005829 | cytosol | 1.34e-01 | 1.00e+00 | 0.672 | 7 | 88 | 1787 |
GO:0005634 | nucleus | 1.38e-01 | 1.00e+00 | 0.463 | 11 | 158 | 3246 |
GO:0006464 | cellular protein modification process | 1.40e-01 | 1.00e+00 | 2.738 | 1 | 4 | 61 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 1.40e-01 | 1.00e+00 | 2.738 | 1 | 4 | 61 |
GO:0007010 | cytoskeleton organization | 1.40e-01 | 1.00e+00 | 2.738 | 1 | 4 | 61 |
GO:0010467 | gene expression | 1.41e-01 | 1.00e+00 | 1.190 | 3 | 49 | 535 |
GO:0051015 | actin filament binding | 1.44e-01 | 1.00e+00 | 2.691 | 1 | 2 | 63 |
GO:0050821 | protein stabilization | 1.46e-01 | 1.00e+00 | 2.668 | 1 | 3 | 64 |
GO:0030018 | Z disc | 1.46e-01 | 1.00e+00 | 2.668 | 1 | 3 | 64 |
GO:0008285 | negative regulation of cell proliferation | 1.47e-01 | 1.00e+00 | 1.555 | 2 | 11 | 277 |
GO:0006629 | lipid metabolic process | 1.48e-01 | 1.00e+00 | 2.646 | 1 | 2 | 65 |
GO:0003676 | nucleic acid binding | 1.50e-01 | 1.00e+00 | 2.624 | 1 | 4 | 66 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 1.52e-01 | 1.00e+00 | 2.602 | 1 | 1 | 67 |
GO:0030308 | negative regulation of cell growth | 1.59e-01 | 1.00e+00 | 2.539 | 1 | 3 | 70 |
GO:0030496 | midbody | 1.65e-01 | 1.00e+00 | 2.479 | 1 | 6 | 73 |
GO:0008289 | lipid binding | 1.65e-01 | 1.00e+00 | 2.479 | 1 | 4 | 73 |
GO:0001649 | osteoblast differentiation | 1.67e-01 | 1.00e+00 | 2.459 | 1 | 5 | 74 |
GO:0015630 | microtubule cytoskeleton | 1.69e-01 | 1.00e+00 | 2.440 | 1 | 5 | 75 |
GO:0005524 | ATP binding | 1.71e-01 | 1.00e+00 | 0.868 | 4 | 37 | 892 |
GO:0030529 | ribonucleoprotein complex | 1.83e-01 | 1.00e+00 | 2.311 | 1 | 5 | 82 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.87e-01 | 1.00e+00 | 2.276 | 1 | 5 | 84 |
GO:0000209 | protein polyubiquitination | 2.03e-01 | 1.00e+00 | 2.145 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 2.03e-01 | 1.00e+00 | 2.145 | 1 | 6 | 92 |
GO:0006260 | DNA replication | 2.07e-01 | 1.00e+00 | 2.114 | 1 | 9 | 94 |
GO:0005509 | calcium ion binding | 2.13e-01 | 1.00e+00 | 1.213 | 2 | 9 | 351 |
GO:0008017 | microtubule binding | 2.13e-01 | 1.00e+00 | 2.069 | 1 | 9 | 97 |
GO:0006457 | protein folding | 2.13e-01 | 1.00e+00 | 2.069 | 1 | 5 | 97 |
GO:0044267 | cellular protein metabolic process | 2.14e-01 | 1.00e+00 | 1.209 | 2 | 14 | 352 |
GO:0006413 | translational initiation | 2.17e-01 | 1.00e+00 | 2.039 | 1 | 6 | 99 |
GO:0016887 | ATPase activity | 2.19e-01 | 1.00e+00 | 2.025 | 1 | 5 | 100 |
GO:0034641 | cellular nitrogen compound metabolic process | 2.29e-01 | 1.00e+00 | 1.954 | 1 | 5 | 105 |
GO:0005769 | early endosome | 2.36e-01 | 1.00e+00 | 1.900 | 1 | 3 | 109 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.37e-01 | 1.00e+00 | 1.110 | 2 | 21 | 377 |
GO:0042981 | regulation of apoptotic process | 2.42e-01 | 1.00e+00 | 1.861 | 1 | 4 | 112 |
GO:0043005 | neuron projection | 2.44e-01 | 1.00e+00 | 1.848 | 1 | 6 | 113 |
GO:0000287 | magnesium ion binding | 2.48e-01 | 1.00e+00 | 1.823 | 1 | 4 | 115 |
GO:0005578 | proteinaceous extracellular matrix | 2.48e-01 | 1.00e+00 | 1.823 | 1 | 4 | 115 |
GO:0007049 | cell cycle | 2.48e-01 | 1.00e+00 | 1.823 | 1 | 8 | 115 |
GO:0006355 | regulation of transcription, DNA-templated | 2.55e-01 | 1.00e+00 | 0.772 | 3 | 31 | 715 |
GO:0006974 | cellular response to DNA damage stimulus | 2.59e-01 | 1.00e+00 | 1.750 | 1 | 11 | 121 |
GO:0000398 | mRNA splicing, via spliceosome | 2.72e-01 | 1.00e+00 | 1.668 | 1 | 15 | 128 |
GO:0016032 | viral process | 2.84e-01 | 1.00e+00 | 0.927 | 2 | 30 | 428 |
GO:0015629 | actin cytoskeleton | 2.86e-01 | 1.00e+00 | 1.581 | 1 | 5 | 136 |
GO:0031625 | ubiquitin protein ligase binding | 2.90e-01 | 1.00e+00 | 1.560 | 1 | 7 | 138 |
GO:0005759 | mitochondrial matrix | 2.91e-01 | 1.00e+00 | 1.550 | 1 | 7 | 139 |
GO:0044212 | transcription regulatory region DNA binding | 2.98e-01 | 1.00e+00 | 1.509 | 1 | 13 | 143 |
GO:0001701 | in utero embryonic development | 3.17e-01 | 1.00e+00 | 1.402 | 1 | 7 | 154 |
GO:0005874 | microtubule | 3.33e-01 | 1.00e+00 | 1.320 | 1 | 10 | 163 |
GO:0008380 | RNA splicing | 3.36e-01 | 1.00e+00 | 1.302 | 1 | 21 | 165 |
GO:0007067 | mitotic nuclear division | 3.36e-01 | 1.00e+00 | 1.302 | 1 | 9 | 165 |
GO:0016071 | mRNA metabolic process | 3.44e-01 | 1.00e+00 | 1.259 | 1 | 10 | 170 |
GO:0016020 | membrane | 3.44e-01 | 1.00e+00 | 0.431 | 4 | 56 | 1207 |
GO:0005730 | nucleolus | 3.50e-01 | 1.00e+00 | 0.419 | 4 | 74 | 1217 |
GO:0005102 | receptor binding | 3.51e-01 | 1.00e+00 | 1.225 | 1 | 3 | 174 |
GO:0006412 | translation | 3.57e-01 | 1.00e+00 | 1.193 | 1 | 12 | 178 |
GO:0006954 | inflammatory response | 3.68e-01 | 1.00e+00 | 1.137 | 1 | 3 | 185 |
GO:0016070 | RNA metabolic process | 3.73e-01 | 1.00e+00 | 1.114 | 1 | 10 | 188 |
GO:0005525 | GTP binding | 3.87e-01 | 1.00e+00 | 1.046 | 1 | 12 | 197 |
GO:0043065 | positive regulation of apoptotic process | 3.95e-01 | 1.00e+00 | 1.010 | 1 | 7 | 202 |
GO:0043234 | protein complex | 4.07e-01 | 1.00e+00 | 0.954 | 1 | 13 | 210 |
GO:0019899 | enzyme binding | 4.07e-01 | 1.00e+00 | 0.954 | 1 | 7 | 210 |
GO:0007275 | multicellular organismal development | 4.13e-01 | 1.00e+00 | 0.927 | 1 | 9 | 214 |
GO:0006200 | ATP catabolic process | 4.20e-01 | 1.00e+00 | 0.894 | 1 | 13 | 219 |
GO:0003682 | chromatin binding | 4.66e-01 | 1.00e+00 | 0.691 | 1 | 15 | 252 |
GO:0000139 | Golgi membrane | 4.86e-01 | 1.00e+00 | 0.608 | 1 | 2 | 267 |
GO:0043565 | sequence-specific DNA binding | 4.97e-01 | 1.00e+00 | 0.565 | 1 | 8 | 275 |
GO:0005925 | focal adhesion | 5.05e-01 | 1.00e+00 | 0.529 | 1 | 14 | 282 |
GO:0009986 | cell surface | 5.17e-01 | 1.00e+00 | 0.484 | 1 | 5 | 291 |
GO:0000278 | mitotic cell cycle | 5.44e-01 | 1.00e+00 | 0.374 | 1 | 28 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 5.48e-01 | 1.00e+00 | 0.360 | 1 | 17 | 317 |
GO:0043066 | negative regulation of apoptotic process | 5.53e-01 | 1.00e+00 | 0.338 | 1 | 8 | 322 |
GO:0006366 | transcription from RNA polymerase II promoter | 5.74e-01 | 1.00e+00 | 0.255 | 1 | 23 | 341 |
GO:0048471 | perinuclear region of cytoplasm | 5.78e-01 | 1.00e+00 | 0.242 | 1 | 11 | 344 |
GO:0042802 | identical protein binding | 5.88e-01 | 1.00e+00 | 0.201 | 1 | 15 | 354 |
GO:0005515 | protein binding | 5.99e-01 | 1.00e+00 | -0.019 | 10 | 198 | 4124 |
GO:0005789 | endoplasmic reticulum membrane | 6.22e-01 | 1.00e+00 | 0.072 | 1 | 7 | 387 |
GO:0044281 | small molecule metabolic process | 6.27e-01 | 1.00e+00 | -0.053 | 2 | 35 | 844 |
GO:0005794 | Golgi apparatus | 6.48e-01 | 1.00e+00 | -0.029 | 1 | 6 | 415 |
GO:0042803 | protein homodimerization activity | 6.59e-01 | 1.00e+00 | -0.073 | 1 | 13 | 428 |
GO:0005886 | plasma membrane | 6.63e-01 | 1.00e+00 | -0.132 | 4 | 46 | 1784 |
GO:0045087 | innate immune response | 6.80e-01 | 1.00e+00 | -0.152 | 1 | 12 | 452 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 6.83e-01 | 1.00e+00 | -0.164 | 1 | 29 | 456 |
GO:0046872 | metal ion binding | 6.83e-01 | 1.00e+00 | -0.199 | 2 | 24 | 934 |
GO:0006351 | transcription, DNA-templated | 7.59e-01 | 1.00e+00 | -0.403 | 2 | 47 | 1076 |
GO:0005887 | integral component of plasma membrane | 7.67e-01 | 1.00e+00 | -0.499 | 1 | 8 | 575 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 7.72e-01 | 1.00e+00 | -0.516 | 1 | 22 | 582 |
GO:0007165 | signal transduction | 7.92e-01 | 1.00e+00 | -0.603 | 1 | 24 | 618 |
GO:0070062 | extracellular vesicular exosome | 7.94e-01 | 1.00e+00 | -0.427 | 3 | 51 | 1641 |
GO:0005615 | extracellular space | 8.09e-01 | 1.00e+00 | -0.678 | 1 | 15 | 651 |
GO:0005576 | extracellular region | 8.15e-01 | 1.00e+00 | -0.704 | 1 | 15 | 663 |
GO:0003677 | DNA binding | 9.14e-01 | 1.00e+00 | -1.219 | 1 | 52 | 947 |
GO:0016021 | integral component of membrane | 9.83e-01 | 1.00e+00 | -1.907 | 1 | 19 | 1526 |